**PURPOSE:** The use of intravenous (IV) heparin following digital replantation or revascularization (DRR) varies greatly. The lack of evidence does not provide the clinical equipoise needed for a randomized trial; as such, a matched propensity score analysis was performed to evaluate the use of post-operative heparinization following DRR.

**METHODS:** A retrospective cohort of patients who underwent DRR from 2005 to 2016 was identified. A propensity score was calculated based on age, smoking, injury mechanism, procedure type, vein graft and number of digits injured. Patients were matched 1:3 by one standard deviation caliper width of the propensity score, to create two groups of patients with similar risks of receiving IV heparin post-operatively. McNemer test was used to determine differences in failure rates between groups.

**RESULTS:** DRR was performed on 282 patients (92% male; median age: 43 years; 37% smokers). Post-operative heparin was administered in 69 patients (25%), with continuous IV heparin in 34 (49%) and IV heparin with dextran in 35 (51%). Failure occurred in 88 patients (31%), of whom 30% received IV heparin. Heparin-related complications were noted in 6 patients (2%). After propensity score matching, any heparin, heparin alone or with dextran was not found to be associated with failure (p=0.71, p=0.74, p=0.89).

**CONCLUSION:** Among DRR patients with similar predisposing characteristics for post-operative heparin, the use of therapeutic heparin does not appear to have a protective effect against digital failure. Studies are needed to define the role of post-operative heparin in DRR and to justify the risk of its administration.
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